(Press-News.org) Los Angeles, CA – February 18, 2026 - Dr. Vadim Jucaud’s lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of human liver tissue, enabling the study of liver regeneration and immune-mediated allograft rejection in a physiologically relevant human system.
Liver transplantation remains the primary therapeutic option for patients with end-stage liver disease, yet progress in understanding transplant rejection and tissue regeneration has been limited by the lack of experimental models that accurately reflect human liver architecture and immune interactions. Conventional culture systems fail to capture the multicellular organization, vascular complexity, and dynamic immune responses that govern transplant outcomes, limiting their relevance for translational research.
To address these limitations, researchers in Dr. Vadim Jucaud’s laboratory (VJLabs) engineered a vascularized liver tissueoid composed of donor-matched human hepatic progenitor cells and intrahepatic portal vein endothelial cells. Within the first week of dynamic perfusion culture, the tissueoid self-assembled into a perfusable microvascular network, followed by progressive maturation into a functional liver-like tissueoid over a 49-day culture period.
Using this platform, the research team demonstrated sustained tissue viability, preserved vascular integrity, and active hepatic function, including the secretion of albumin, urea, complement factors, and hepatocyte growth factor. The mature liver tissueoid contained multiple liver-relevant cell populations, including hepatocytes, cholangiocytes, Kupffer cells, stellate cells, and endothelial cells, closely reflecting the cellular diversity of native human liver tissue.
The LToC platform was further tested to model immune-mediated allograft rejection by perfusing the mature tissueoid with allogeneic T cells. This exposure induced hallmark features of cellular rejection, including reduced tissue viability, endothelial disruption, loss of hepatic markers, increased HLA-I expression, and a pronounced pro-inflammatory cytokine response. Elevated levels of IL-6, TNF-α, IL-1β, IFN-γ, granzyme A and B, and perforin mirrored immune activation patterns observed during clinical transplant rejection.
“This liver tissueoid-on-a-chip enables us to recreate key aspects of liver regeneration and immune-mediated rejection within a human-relevant, vascularized tissue architecture,” said Dr. Abdul Rahim Chethikkattuveli Salih, first author of the publication.
“By integrating functional vasculature, multiple liver cell types, and immune responsiveness into a single platform, this system allows us to study transplant biology in a more physiologically meaningful way,” added Dr. Vadim Jucaud, Principal Investigator and Assistant Professor at the Terasaki Institute. “This approach has the potential to support immunosuppressive drug evaluation and advance more personalized strategies for liver transplantation.”
This work contributes to the legacy of Dr. Paul I. Terasaki in organ transplantation research, with the overarching goal of improving the quality of life for transplant patients.
“Dr. Terasaki believed that meaningful innovation in transplantation must always be driven by its potential to improve patients’ lives,” said Dr. Jucaud. “As one of the last doctoral scholars trained by Dr. Paul I. Terasaki, carrying forward his vision, through innovative, translational science that bridges engineering, immunology, and transplantation, holds deep personal significance to me.”
This commitment continues at the Terasaki Institute, where advancing patient-centered, translational technologies remains a guiding principle and a tribute to Dr. Terasaki’s lasting impact on the field.
A link to the publication can be found here:
https://doi.org/10.1002/adma.202521178
A link to Dr. Vadim Jucaud’s lab page can be found here:
https://terasaki.org/institute/research/investigators/vadim-jucaud-laboratory.html
For more information, please contact:
Vadim Jucaud, Ph.D.
Assistant Professor
Email: vjucaud@terasaki.org
About the Terasaki Institute for Biomedical Innovation
The Terasaki Institute for Biomedical Innovation is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. The Institute aims to enhance the quality of human life through translational research and the acceleration of biomedical innovation. TIBI's research focuses on the development of biomaterials, cellular and tissue engineering, medical devices, and microfluidic systems.
END
A new vascularized tissueoid-on-a-chip model for liver regeneration and transplant rejection
2026-02-18
ELSE PRESS RELEASES FROM THIS DATE:
Augmented reality menus may help restaurants attract more customers, improve brand perceptions
2026-02-18
EVERETT, Wash. – Restaurants looking for new ways to engage and inform customers may benefit from incorporating augmented reality (AR) technology into their menus, according to new research from Washington State University.
The study, published in the International Journal of Hospitality Management, finds that AR menus can significantly increase customers’ interest in visiting a restaurant and may result in more positive word-of-mouth marketing, when compared to printed or QR-code menus.
Led by Soobin Seo, professor of hospitality business ...
Power grids to epidemics: study shows small patterns trigger systemic failures
2026-02-18
Why do some systems collapse suddenly after what seems like a minor disturbance? A single transmission line failure can cascade into widespread blackouts. A delayed shipment can ripple through a global supply chain, emptying store shelves far from the original disruption. A rumor spreading in a small online network can spark nationwide panic. In nature, a slight environmental shift can throw an ecosystem into chaos, and a local disease outbreak can quickly escalate into an epidemic.
New research suggests that in many of these cases, ...
Computational insights into the interactions of andrographolide derivative SRJ09 with histone deacetylase for the management of beta thalassemia
2026-02-18
Background and objectives
Thalassemia is a group of anemias that result from inherited defects in the production of the beta chain of hemoglobin. It is stabilized by gamma globin, which combines to form fetal hemoglobin. One therapeutic approach is to target histone deacetylase (HDAC), which plays an important role in controlling beta thalassemia. This study sought to identify a natural inducer for treating this disease.
Methods
Twenty-five Andrographis paniculata compounds were screened using Schrödinger Suite 2020 (Maestro 12.3) for ligand preparation, grid generation, glide extra precision docking and molecular mechanics/generalized ...
A genetic brake that forms our muscles
2026-02-18
In an international study, researchers at Lund University in Sweden have identified a gene variant that controls the body’s capability to form new blood vessels in muscles – a mechanism that affects physical performance, health and recovery. The favourable gene variant is considerably more common among top athletes in endurance sports, compared with both top athletes in explosive sports and non-athletes.
Key facts
• Discovery: The gene RAB3GAP2 regulates the number of blood vessels in muscles.
• Significance: Affects muscle function, endurance and metabolism.
• Sports: The favourable variant ...
CHEST announces first class of certified critical care advanced practice providers awarded CCAPP Designation
2026-02-18
Glenview, Illinois –The American College of Chest Physicians (CHEST) is pleased to announce the first class of advanced practice providers (APPs) to earn the CHEST Critical Care Advanced Practice Provider (CCAPP) designation.
Available to nurse practitioners and physician assistants/associates, this achievement underscores the dedication of the APP to maintaining the highest professional standards and commitment to patient-centered care.
The CCAPP designation recognizes APPs who play an essential role on the critical care team and support high-quality care for patients who are critically ill across ICU settings.
“Earning ...
Jeonbuk National University researchers develop an innovative prussian-blue based electrode for effective and efficient cesium removal
2026-02-18
Radioactive cesium ions, due to their high-water solubility, pose a serious threat to human health and the environment. Conventional adsorbents such as Prussian blue (PB), although effective for cesium removal, often involve complex fabrication and high operational costs. Researchers have now developed an innovative electrochemical electrode by depositing PB onto chemically treated carbon cloth, achieving high cesium adsorption capacity and excellent reusability, with strong potential for practical wastewater treatment applications.
Although regarded as a clean and sustainable energy source, nuclear fission requires ...
Self-organization of cell-sized chiral rotating actin rings driven by a chiral myosin
2026-02-18
Living cells are highly organized, yet they are not assembled using rigid blueprints or by following a predetermined plan. Instead, order emerges on its own from countless interactions between molecules that are constantly moving and rearranging. One of the most striking examples of this emerging order is the left–right asymmetry. This type of chirality—the property of an object that makes it different from its mirror image—is essential for many biological processes and can be observed throughout nature. Interestingly, how both small- and large-scale order arise from interactions ...
Report: US history polarizes generations, but has potential to unite
2026-02-18
While there are plenty of historical topics U.S. citizens agree on—generally events and figures from the Civil War up to the end of the Cold War—the birth of the nation isn’t one of them, according to a new report from Johns Hopkins SNF Agora Institute and a nonprofit called Millions of Conversations.
The country’s founding has become one of the most polarizing eras in history, the new research finds, just as the United States is starting to celebrate its 250th anniversary this year.
Older generations in the survey believe American ...
Tiny bubbles, big breakthrough: Cracking cancer’s “fortress”
2026-02-18
CLEVELAND—Researchers at Case Western Reserve University have discovered a way to breach one of cancer’s most stubborn defenses: the impenetrable fortress that solid tumors build around themselves.
By injecting nanobubbles filled with inert gas into tumors and “jiggling” them with ultrasound, the team successfully broke down tumor barriers enough for treatment-bearing molecules to get inside, according to results of a new study published in ACS Nano.
“The physical barrier is limiting delivery of cancer drugs, especially for new immunotherapies,” ...
A biological material that becomes stronger when wet could replace plastics
2026-02-18
Plastics have become an integral part of modern society thanks to their durability and resistance to water. However, precisely these properties turn them into persistent disruptors of ecological cycles. As a result, unrecovered plastic is accumulating across ecosystems and becoming an increasingly ubiquitous component of global food chains, raising growing concerns about potential impacts on human health.
In an effort to address this challenge, the use of biomaterials as substitutes for conventional plastics has long been explored. However, their widespread adoption has been limited by a fundamental drawback: most biological materials weaken when ...